Corrigendum to ‘3161 – CELLULAR AND MOLECULAR EFFECTS OF DMPGE₂ RADIOMITIGATION IN MOUSE AND HUMAN BONE MARROW CELLS IN VIVO USING C57BL/6 AND HUMANIZED NSG MOUSE MODELS OF ACUTE RADIATION SYNDROME’ [Volume 111, Supplement, 2022, Page S125]

The Authors regret that in the original abstract, Dr. Christie Orschell was listed as second author which incorrect. correct Author line is shown above. 3161 – CELLULAR AND MOLECULAR EFFECTS OF DMPGE₂ RADIOMITIGATION IN MOUSE HUMAN BONE MARROW CELLS VIVO USING C57BL/6 HUMANIZED NSG MODELS ACUTE RADIATION SYNDROMEExperimental HematologyVol. 111PreviewThe hematopoietic system highly sensitive to radiation exposure, and bone marrow (BM) failure from acute syndrome (H-ARS) primary threat human life following a nuclear accident or attack. Dimethyl prostaglandin E2 (dmPGE₂) promising medical countermeasure (MCM) significantly increases H-ARS survival mice. Here mechanisms of dmPGE₂ radiomitigation were defined when given 24 h post-total body irradiation (TBI) mice humanized NOD scid gamma null (NSG) Full-Text PDF